Calumet Specialty Products Partners, L.P (NASDAQ:CLMT)’s share price traded up 3.9% during trading on Friday . The stock traded as high as $5.11 and last traded at $5.09, with a volume of 208,658 shares traded. The stock had previously closed at $4.90.

Several equities analysts have commented on the stock. Howard Weil dropped their price target on shares of Calumet Specialty Products Partners, L.P from $19.00 to $5.00 and set a “sector underperform” rating for the company in a research note on Monday, April 18th. Janney Montgomery Scott downgraded shares of Calumet Specialty Products Partners, L.P from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $17.00 to $8.00 in a research note on Monday, April 18th. Raymond James Financial Inc. downgraded shares of Calumet Specialty Products Partners, L.P from a “market perform” rating to an “underperform” rating in a research note on Monday, April 18th. Royal Bank Of Canada downgraded shares of Calumet Specialty Products Partners, L.P from an “outperform” rating to a “sector perform” rating and lowered their target price for the stock from $22.00 to $7.00 in a research note on Monday, April 18th. Finally, Wells Fargo & Co. downgraded shares of Calumet Specialty Products Partners, L.P from an “outperform” rating to a “market perform” rating in a research note on Monday, April 18th. Six analysts have rated the stock with a sell rating and nine have given a hold rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $10.71.

The company’s 50 day moving average price is $4.72 and its 200 day moving average price is $7.74. The firm’s market capitalization is $390.26 million.

Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) last issued its earnings results on Thursday, August 4th. The company reported ($1.89) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.34) by $1.55. Equities analysts anticipate that Calumet Specialty Products Partners, L.P will post ($1.77) EPS for the current fiscal year.

In other Calumet Specialty Products Partners, L.P news, Director Stephen P. Mawer bought 11,000 shares of the business’s stock in a transaction dated Wednesday, May 18th. The shares were acquired at an average price of $3.68 per share, with a total value of $40,480.00. Following the purchase, the director now owns 5,025 shares in the company, valued at approximately $18,492. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, Director James S. Carter bought 26,700 shares of the business’s stock in a transaction dated Tuesday, May 17th. The stock was acquired at an average cost of $3.72 per share, for a total transaction of $99,324.00. Following the purchase, the director now owns 66,341 shares in the company, valued at approximately $246,788.52. The disclosure for this purchase can be found here.

A hedge fund recently bought a new stake in Calumet Specialty Products Partners, L.P stock. Marshall Wace LLP bought a new position in shares of Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 209,614 shares of the company’s stock, valued at approximately $4,173,000. Marshall Wace LLP owned about 0.28% of Calumet Specialty Products Partners, L.P at the end of the most recent reporting period.

Calumet Specialty Products Partners, L.P. is a producer of specialty hydrocarbon products. The Company operates through three segments. In its specialty products segment, the Company processes crude oil and other feedstocks into a range of customized lubricating oils, white mineral oils, solvents, petrolatums and waxes.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.